Laddar...
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues upon dose escalation, ADCs utilize monoclonal antibodies (mAbs) to specifically bind tumour-associated target antigens and...
Sparad:
| I publikationen: | Biosci Rep |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Portland Press Ltd.
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613712/ https://ncbi.nlm.nih.gov/pubmed/26182432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20150089 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|